Literature DB >> 22879780

Hypertrophic scarring in cleft lip repair: a comparison of incidence among ethnic groups.

Ali M Soltani1, Cameron S Francis, Arash Motamed, Ashley L Karatsonyi, Jeffrey A Hammoudeh, Pedro A Sanchez-Lara, John F Reinisch, Mark M Urata.   

Abstract

BACKGROUND: Although hypertrophic scar (HTS) formation following cleft lip repair is relatively common, published rates vary widely, from 1% to nearly 50%. The risk factors associated with HTS formation in cleft patients are not well characterized. The primary aim of this retrospective study of 180 cleft lip repairs is to evaluate the frequency of postoperative HTS among various ethnic groups following cleft lip repair.
METHODS: A retrospective chart view of patients undergoing primary cleft lip repair over a 16-year period (1990-2005) by the senior surgeon was performed. The primary outcome was the presence of HTS at 1 year postoperatively. Bivariate analysis and multivariable logistic regression were used to evaluate potential risk factors for HTS, including ethnicity, type and laterality of cleft, and gender.
RESULTS: One hundred and eighty patients who underwent cleft lip repair were included in the study. The overall rate of postoperative HTS formation was 25%. Ethnicity alone was found to be an independent predictor of HTS formation. Caucasian patients had the lowest rate of HTS formation (11.8%) and were used as the reference group. HTS rates were significantly higher in the other ethnicities, 32.2% in Hispanic patients (odds ratio [OR]: 3.51; 95% confidence interval [CI]: 1.53-8.85), and 36.3% for Asian patients (OR 4.27; 95% CI: 1.36-13.70). Sex, cleft type, and cleft laterality were not associated with increased rates of HTS.
CONCLUSIONS: Differences in ethnic makeup of respective patient populations may be a major factor influencing the wide variability of reported HTS rates. Consideration should be given to potential prophylactic treatments for HTS in susceptible ethnic populations.

Entities:  

Keywords:  cleft lip; epidemiology; ethnicity; hypertrophic scarring

Year:  2012        PMID: 22879780      PMCID: PMC3413167          DOI: 10.2147/CLEP.S31119

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   4.790


Introduction

Cleft lip (with or without cleft palate) is the most commonly reported congenital anomaly requiring surgery, occurring at a rate of 79.1 per 100,000 live births.1 In California, the incidence of cleft lip (with or without cleft palates) is 74.1 per 100,000 live births.2 This congenital malformation is referred to pediatric plastic surgeons and requires early repair for functional, esthetic, and psychosocial reasons. Hypertrophic scar (HTS) formation is a postoperative complication of cleft lip repair and may often require surgical revision. The pathogenesis of hypertrophic scars is not clear and much of our understanding is from anecdotal, clinical experience. Normal wound healing progresses through well recognized and refined phases. The initial period of hyperemia represents revascularization. This is followed by collagen realignment and wound maturation. In a subset of patients, the normal physiologic scar maturation process becomes unregulated. The reorganization of collagen may lead to aberrant growth within the margins, which may present as elevated, pruritic, and sometimes painful scar that can be classified as hypertrophic. Hypertrophic scarring generally occurs within 3–6 months following the initial injury. Once formed the scar may remain static in size or begin to regress.3,4 This regression in the cleft lip patient can lead to a shortened lip on the affected side. HTS remains confined within the site of the original wound, increasing in size primarily through growth in the perpendicular plane rather than lateral invasion.5 In the perioral region, HTS formation can result in esthetically deforming scars that may lead to secondary cleft lip revision. Aberrant scar formation following cleft lip repair is associated with lip asymmetry and nasal stenosis. Rates of HTS formation following cleft lip repair have rarely been reported and those that have vary widely, from 8% to 47% according to various authors.6–9 In addition, there appears to be no data addressing patient and demographic factors associated with subsequent HTS formation. Our experience at the Children’s Hospital Los Angeles suggests a higher rate of hypertrophic scarring in Hispanic and Asian populations. To our knowledge, there are no published studies that compare the rate of hypertrophic scarring among various ethnic groups after cleft lip repair. The aim of this study is to determine differences that may exist between ethnicities with respect to the formation of HTS following primary cleft lip repair.

Materials and methods

After obtaining institutional review board approval, we conducted a retrospective chart review of all patients who underwent primary cleft lip repair by a single surgeon (JF Reinisch) at Children’s Hospital Los Angeles from June 1990 to June 2005. For all patients, cleft lip repair was performed using a standard rotational-advancement technique. Skin closure was accomplished with multiple interrupted dermal 6-0 polydioxanone sutures followed by either Dermabond (Ethicon, Inc, Somerville, NJ) or Steri-Strips (3M Company, St Paul, MN). Postoperatively, all patients received long-term longitudinal follow-up through enrollment in the CHLA cleft team. Each patient’s admission sheet was reviewed to identify the ethnicity of the patient, as stated by the patients’ parents/guardians. Available choices were Hispanic, Caucasian, Asian, African American, and other. Data were abstracted from progress notes written by the senior author, and based on digital photographic records. Each chart was reviewed for documentation of HTS at 1-year post-primary cleft lip repair (+/−3 months). Specifically, patients were screened for HTS based on any references in the follow-up clinic notes to scars that were thick, reddened, irregular, or hypertrophic. For each patient with positive findings on the chart review, the diagnosis of HTS was confirmed using photographic records by the study team if the scar appeared to be wider than 3 mm with a pink or red color. Two examples of patients with HTS are shown; Figure 1 demonstrates a child with a right unilateral cleft lip HTS, and in Figure 2 an HTS developed on the right side in a patient with bilateral cleft lip repair. Further, the patient’s gender, cleft classification, and type of cleft (ie, unilateral vs bilateral and incomplete vs complete) were recorded. Patients with disorders or conditions that could impair wound healing such as Ehlers–Danlos or Marfan syndromes were excluded. A history of previous hypertrophic or keloid scarring was also considered an exclusion criterion; however, this applied to no patients in our study. Due to small sample size (1), African American patients were excluded from the statistical analysis as were patients with ethnicity identified as other.
Figure 1

Right unilateral cleft lip hypertrophic scar.

Figure 2

Bilateral cleft lip, hypertrophic scar on right side.

Data were analyzed using the software JMP (v 9; SAS Institute Inc, Cary, NC). Bivariate statistics (Fisher’s exact tests) were used to analyze HTS rates in patients stratified by risk factors including ethnicity, cleft laterality (unilateral or bilateral), gender, and cleft type (incomplete or complete). To identify independent predictors of HTS formation, multivariable logistic regression was performed using the same risk factors from the stratified analysis as independent variables. HTS was used as the dependent variable for the regression model. A value of P < 0.05 was considered statistically significant.

Results

The charts of 186 patients who underwent primary cleft lip repair were reviewed. Of these, 180 met the inclusion criteria. The remaining six were excluded from the study because of previously mentioned exclusion criteria or incomplete information regarding the patients’ scars, race, or follow-up. The average age was 4.3 months at the time of cleft lip repair, which was similar between ethnic populations. The overall presence of cleft lip hypertrophic scarring was noted in 25% of patients with the remaining 75% displaying normal wound healing. Bivariate analysis of HTS rates stratified by risk factor demonstrated a statistically significant difference in the rate of hypertrophic scarring among the three ethnicities (Table 1). The lowest rate of HTS formation was observed in Caucasians (11.8%) compared with Hispanics (32.2%) and Asians (36.3%). Multivariable regression analysis revealed ethnicity to be the only independent predictor of HTS formation among the potential risk factors considered, with elevated odds ratios (ORs) observed in Asian (OR: 4.27; 95% confidence interval [CI]: 1.36–13.70; P = 0.014) and Hispanic (OR: 3.51; 95% CI: 1.53–8.85; P = 0.003) patients, compared with Caucasians (Table 2).
Table 1

Bivariate statistics analyzing HTS rates stratified by risk factors

Risk factorNoHTS rate (%)P-value
Sex
 Female6725.4>0.999
 Male11324.8Reference
Ethnicity
 Asian2236.30.021*
 Hispanic9032.20.003*
 Caucasian6811.8Reference
Cleft characteristics
 Bilateral3528.60.664
 Unilateral14524.1Reference
 Complete10328.10.389
 Incomplete7720.7Reference

Note:

Indicates statistical significance at the level of 0.05.

Table 2

Multivariable logistic regression to identify independent predictors of HTS post-cleft lip repair

Risk factorOdds ratio (95% CI)P-value
Sex
 Female1.05 (0.51–2.19)0.893
 MaleReference
Ethnicity
 Asian4.27 (1.36–13.70)0.014*
 Hispanic3.51 (1.53–8.85)0.003*
 CaucasianReference
Cleft characteristics
 Bilateral1.28 (0.52–2.98)0.572
 UnilateralReference
 Complete1.27 (0.63–2.62)0.506
 IncompleteReference

Note:

Indicates statistical significance at the level of 0.05.

Abbreviations: CI, confidence intervals; HTS, hypertrophic scar.

Discussion

Determining the accurate frequency of hypertrophic scarring presents numerous challenges when attempting to compare published rates among various ethnicities. There are many confounding factors such as the age of the patient, nature and location of the wound, time at which the wound is evaluated, and subjectivity on the surgeon’s part associated with the qualitative assessment of the scar. This paper mitigates many of these variables by evaluating the data on hypertrophic scarring following cleft lip repair for various ethnicities within our institution and relying on the assessment of our senior plastic surgeon with extensive clinical experience in this field. Further, these assessments were confirmed through patient photographic records. Our HTS rate in Caucasians is comparable to published literature from the UK on cleft lip repair, 12%–18%.6 Similarly, our HTS rate in Asians is comparable to rates published by Japanese surgeons, up to 27%.8,9 The majority of published reports have investigated the formation of HTS as a complication of thermal injuries, which appear to have a higher frequency than those associated with surgical wounds.10 Additionally, most studied subjects have been adults and there is evidence that the intensity of scar formation differs with age.3 Nevertheless, the reported incidence of HTS in adults ranges from 37% to 68% for surgical wounds and 33% to 91% for thermal injuries.6,11–13 In burn patients under the age of 5 years, hypertrophic scarring incidence ranges from 30% to 65%,14,15 while in children between 6 and 15 years of age, the incidence is approximately 50%.13 We noted a high rate of HTS in our pigmented pediatric population undergoing primary cleft lip surgery. In comparison, the adult, Chinese population is reported to have an incidence of 74.7%16 1 month after orthopedic surgery and 44.6%6 following linear orthopedic procedures. While literature on the Hispanic population is lacking, the incidence of hypertrophic scarring for the fair-skinned, Northern European population has been stated to be up to 37% following median sternotomy,10 however these areas (chest, extremities) are under tension and are subject to poorer scarring. Lastly, one study on thermal injuries has reported that African Americans fare worse than Caucasians in hypertrophic scar development.17 In determining the rate of hypertrophic scarring among various races, our study was limited by the lack of African American subjects (one patient, excluded from analysis), which in part may be a reflection of Los Angeles County’s demographics where 47.3% are Hispanic, 29.2% are White, 13.1% are Asian, and 9.6% are African American.18 Moreover, the incidence of orofacial clefts varies with race such that Asians have the highest incidence, followed by Caucasians, Hispanics, and African Americans.17,19–22 Our data agrees with the literature and the anecdotal experience that darker pigmented individuals have a higher frequency of hypertrophic scarring. Additionally, a study that had investigated HTS incidence following thermal injuries had reported the incidence to be 75% in non-Caucasians patients and 60% in Caucasian patients.23 This study did not show a correlation between gender and HTS. This lack of association is consistent with studies on Chinese and darker pigmented individuals which did not show a significant difference in HTS between female and male groups.15,24 Furthermore, we found no statistical association between hypertrophic scarring incidences in unilateral vs bilateral and incomplete vs complete cleft lips. This study, however, does clearly demonstrate a higher frequency of hypertrophic scarring in the non-Caucasian group, regardless of gender, laterality, and type of cleft. Hypertrophic cleft lip scars can cause emotional and mental distress along with functional and esthetic complications leading to frequent secondary cleft lip revisions. These cleft lip revisions can cause increased parental and patient stress, added anesthetic and surgical risks, and increased parental and societal costs. If a patient does develop HTS following cleft lip repair, there are various treatment modalities available. If erythema or pruritis is the prevailing complaint, intralesional steroids may be injected. Further, silicone taping has been shown to flatten and improve the appearance of the hypertrophic scar postoperatively. There are few proven techniques that prevent hypertrophic scarring, but following meticulous surgical technique with precise alignment of the skin can possibly reduce this risk. Ultimately, many patients with hypertrophic scarring or contracture post cleft lip repair may require a scar revision or z-plasty for scar camouflage. However, even with this surgical treatment, it may still recur. Our study illustrates that in the pediatric population, 1 year following cleft lip repair, Asian and Hispanic populations have three times the rate of hypertrophic scarring than do Caucasians. Further studies can enhance our comprehension of the potential genetic, environmental, and social reasons behind these results. These data lend credence to our initial clinical impression and provides incentive to further explore potential prophylactic treatments for hypertrophic scars in susceptible populations.
  22 in total

1.  Prevalence of hypertrophic scar formation and its characteristics among the Chinese population.

Authors:  Cecilia W P Li-Tsang; Joy C M Lau; Chetwyn C H Chan
Journal:  Burns       Date:  2005-04-02       Impact factor: 2.744

Review 2.  Topical treatments for hypertrophic scars.

Authors:  Joanna M Zurada; David Kriegel; Ira C Davis
Journal:  J Am Acad Dermatol       Date:  2006-09-18       Impact factor: 11.527

3.  Time trends in incidence of hypertrophic scarring in children treated for burns.

Authors:  Z Dedovic; I Koupilová; P Brychta
Journal:  Acta Chir Plast       Date:  1999

4.  A randomized comparison of triangular and rotation-advancement unilateral cleft lip repairs.

Authors:  B Holtmann; R C Wray
Journal:  Plast Reconstr Surg       Date:  1983-02       Impact factor: 4.730

Review 5.  The geographical distribution of neural tube defects and oral clefts.

Authors:  I Leck
Journal:  Br Med Bull       Date:  1984-10       Impact factor: 4.291

6.  Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992.

Authors:  L A Croen; G M Shaw; C R Wasserman; M M Tolarová
Journal:  Am J Med Genet       Date:  1998-08-27

7.  Dermabond tissue adhesive versus Steri-Strips in unilateral cleft lip repair: an audit of infection and hypertrophic scar rates.

Authors:  Andrew D H Wilson; Nigel Mercer
Journal:  Cleft Palate Craniofac J       Date:  2008-01-23

8.  What is the prevalence of hypertrophic scarring following burns?

Authors:  Kristine M Bombaro; Loren H Engrav; Gretchen J Carrougher; Shelly A Wiechman; Lee Faucher; Beth A Costa; David M Heimbach; Frederick P Rivara; Shari Honari
Journal:  Burns       Date:  2003-06       Impact factor: 2.744

9.  Hypertrophic burn scars: analysis of variables.

Authors:  E A Deitch; T M Wheelahan; M P Rose; J Clothier; J Cotter
Journal:  J Trauma       Date:  1983-10

10.  The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation.

Authors:  F B Niessen; P H Spauwen; P H Robinson; V Fidler; M Kon
Journal:  Plast Reconstr Surg       Date:  1998-11       Impact factor: 4.730

View more
  19 in total

1.  Clinical Outcomes Following the Early Application of Multimodal Scar Programs for Facial Incisional Wounds.

Authors:  Joong Min Suh; Seong Hoon Park; Jun Won Lee; Seong Joo Lee; In Suck Suh; Jong Wook Lee; Hii Sun Jeong
Journal:  Aesthetic Plast Surg       Date:  2021-05-10       Impact factor: 2.326

2.  Robotic thyroidectomy by bilateral axillo-breast approach: review of 1,026 cases and surgical completeness.

Authors:  Kyu Eun Lee; Eunyoung Kim; Do Hoon Koo; June Young Choi; Kyu Hyung Kim; Yeo-Kyu Youn
Journal:  Surg Endosc       Date:  2013-02-23       Impact factor: 4.584

Review 3.  Current and Emerging Treatments for Postsurgical Cleft Lip Scarring: Effectiveness and Mechanisms.

Authors:  E Papathanasiou; C A Trotman; A R Scott; T E Van Dyke
Journal:  J Dent Res       Date:  2017-06-26       Impact factor: 6.116

Review 4.  Modulating Cellular Responses to Mechanical Forces to Promote Wound Regeneration.

Authors:  Shamik Mascharak; Heather E desJardins-Park; Michael F Davitt; Nicholas J Guardino; Geoffrey C Gurtner; Derrick C Wan; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-10-08       Impact factor: 4.947

5.  Specialized Pro-Resolving Mediators Reduce Scarring After Cleft Lip Repair.

Authors:  Evangelos Papathanasiou; Andrew R Scott; Carroll Ann Trotman; Corinna Beale; Lori Lyn Price; Gordon S Huggins; Yang Zhang; Irene Georgakoudi; Thomas E Van Dyke
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

6.  Comma-Shaped Columellar Strut for Nasal Tip Plasty in East Asian Rhinoplasty.

Authors:  Jianjun You; Lehao Wu; Yihao Xu; Fei Fan; Huan Wang
Journal:  Aesthetic Plast Surg       Date:  2020-09-10       Impact factor: 2.326

7.  Association of Pediatric Patient Demographic Factors and Scar Anatomic Features With Scar Outcomes After Surgical Repair of Cleft Lip.

Authors:  Alexander P Marston; Mark S Costello; Zachary Farhood; Kathleen A Brandstetter; Alexander W Murphey; Shaun A Nguyen; Christopher M Discolo; Krishna G Patel
Journal:  JAMA Facial Plast Surg       Date:  2019-09-01       Impact factor: 4.611

8.  A Novel Animal Model for Simulating Scarring After Cleft Lip Repair.

Authors:  Evangelos Papathanasiou; Carroll Ann Trotman; Corinna Beale; Thomas E Van Dyke; Andrew R Scott
Journal:  Facial Plast Surg Aesthet Med       Date:  2021-02-24

9.  Expression Analysis of FGF/FGFR and FOX Family Proteins in Mucosal Tissue Obtained from Orofacial Cleft-Affected Children.

Authors:  Māra Pilmane; Nityanand Jain; Zane Vitenberga-Verza
Journal:  Biology (Basel)       Date:  2021-05-10

10.  Fibromodulin reduces scar size and increases scar tensile strength in normal and excessive-mechanical-loading porcine cutaneous wounds.

Authors:  Wenlu Jiang; Kang Ting; Soonchul Lee; Janette N Zara; Richard Song; Chenshuang Li; Eric Chen; Xinli Zhang; Zhihe Zhao; Chia Soo; Zhong Zheng
Journal:  J Cell Mol Med       Date:  2018-02-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.